Daniel DiPietro
Founder at Modis Therapeutics, Inc.
Network origin in Daniel DiPietro first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.
11
| Private Company | Investment Managers | 11 |
Modis Therapeutics, Inc.
 Modis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Aceras BioMedical LLC
 Aceras BioMedical LLC Investment ManagersFinance Aceras BioMedical LLC (Aceras BioMedical) is a porivate equity/venture capital firm founded in 2008 by Peter barber, Matthew Wyckoff, and Daniel DiPietro. The firm is headquartered in New York, New York.
3
| Private Company | Investment Managers | 3 |
SCO Capital Partners LLC
 SCO Capital Partners LLC Investment ManagersFinance Founded in 1997, SCO Capital Partners LLC is a venture capital firm located in New York City. The firm is a subsidiary of SCO Financial Group LLC.
2
| Private Company | Investment Managers | 2 |
Brooklyn Conservatory of Music
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel DiPietro via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Investment Managers | Chief Executive Officer President General Counsel Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Private Equity Investor | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Director/Board Member | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Public Communications Contact | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| VIOQUEST PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Chairman Director/Board Member | |
Cordova Sciences, Inc.
 Cordova Sciences, Inc. Financial ConglomeratesFinance Cordova Sciences, Inc. operates as a blank check company. It is a development stage company and serves as a vehicle to effect a merger, exchange of capital stock, and asset acquisition. The company was founded on August 12, 2005 and is headquartered in New York, NY. | Financial Conglomerates | President Corporate Secretary | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| EMISPHERE TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale Law School | College/University | Graduate Degree Graduate Degree | |
Adgero Biopharmaceuticals Holdings, Inc.
 Adgero Biopharmaceuticals Holdings, Inc. Medical SpecialtiesHealth Technology Adgero Biopharmaceuticals Holdings, Inc. a biopharmaceutical company. It focuses on the development of photodynamic therapy for the treatment of rare, unmet medical needs, with particular emphasis on orphan cancer indications. The firm offers candidate, REM-001 therapy, consists of three parts, a laser light source, a light delivery device and the drug REM-001. The company is headquartered inv Princeton, NJ. | Medical Specialties | Director/Board Member Chief Executive Officer | |
Meves Pharmaceuticals, Inc.
 Meves Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Sitka Sciences, Inc.
 Sitka Sciences, Inc. Financial ConglomeratesFinance Sitka Sciences, Inc. operates as a development stage company. It intends to acquire or merge with an operating company. The company was founded on August 12, 2005 and is headquartered in Wilmington, DE. | Financial Conglomerates | President Chief Executive Officer | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| DIMENSION THERAPEUTICS INC | Biotechnology | Chairman Founder | |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Symbiomix Therapeutics LLC develops medicines for women’s health infections and related diseases. It offers SYM-1219, a drug that contains secnidazole that facilitate administration as a single-dose oral therapy for various women's health infections including bacterial vaginosis. The company was founded by Jack Roberts, Steve Pomerantz and Joseph L. Amprey III in 2012 and is headquartered in Newark, NJ. | Biotechnology | Director/Board Member Director/Board Member | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| GELESIS INC | Biotechnology | Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chairman | |
| 501 ACQU | Financial Conglomerates | Director/Board Member | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Chairman | |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Iris Medicine, Inc.
 Iris Medicine, Inc. Medical/Nursing ServicesHealth Services Iris Medicine, Inc. is engaged in providing healthcare services. The company was founded by Keith Gagnon and Megan Blewett and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Chairman | |
| Tulane University (Louisiana) | College/University | Undergraduate Degree | |
Wachtell, Lipton, Rosen & Katz
 Wachtell, Lipton, Rosen & Katz Miscellaneous Commercial ServicesCommercial Services Wachtell, Lipton, Rosen & Katz provides advisory and legal services. It specializes in mergers and acquisitions, strategic investments, takeovers and takeover defense, corporate and securities law, and corporate governance. The company was founded in 1965 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Raymond James & Associates, Inc.
 Raymond James & Associates, Inc. Financial ConglomeratesFinance Raymond James & Associates, Inc. (RJA) is a registered broker-dealer headquartered in St. Petersburg, Florida. The firm was founded in 1962 and is a subsidiary of Raymond James Financial, Inc. (NYSE: RJF), a diversified holding company. RJA offers a full array of capital markets services, strategic advice and planning for institutional investors. | Financial Conglomerates | Analyst-Equity | |
Western Water Co.
 Western Water Co. Water UtilitiesUtilities Western Water Co. develops and sells water and water rights. The private company is based in San Diego, CA. The company was founded by Peter L. Jensen. | Water Utilities | Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Gilda's Club New York City, Inc. provides support services to cancer patients. Its programs include cancer support for all, offsite program, and programs for children and teens with cancer. The company was founded by Gene Wilder, Joanna Bull, Mandy Patinkin, and Joel Siegel in 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| SIENTRA, INC. | Medical Specialties | Director/Board Member | |
| NEUROPACE, INC. | Medical Specialties | Director/Board Member | |
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
| VERONA PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Director/Board Member | |
Avitide, Inc.
 Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 48 |
| Canada | 2 |
| China | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 31 |
| Finance | 10 |
| Consumer Services | 4 |
| Health Services | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 107 |
| Corporate Officer/Principal | 53 |
| Founder | 28 |
| President | 28 |
| Chairman | 28 |
Most connected contacts
| Insiders | |
|---|---|
| Rishi Gupta | 29 |
| J. Lobell | 27 |
| Michael Weiser | 26 |
| Lindsay Rosenwald | 23 |
| Stephen Rocamboli | 20 |
| Benjamin Auspitz | 20 |
| Jeffrey Davis | 17 |
| Matt Patterson | 14 |
| Timothy M. Hofer | 14 |
| Tim McInerney | 13 |
| Evan Renov | 12 |
| John Liatos | 9 |
| Scott A. Katzmann | 8 |
| Chad Messer | 8 |
| Henry Choi | 7 |
- Stock Market
- Insiders
- Daniel DiPietro
- Company connections
